Levothyroxine Sodium
Product Images NDC 70934-326
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Levothyroxine Sodium (NDC 70934-326). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Denton Pharma, Inc. Dba Northwind Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Label 50 (70934 273 30 Rev A 02 19)
Label 112 (70934 274 30 Rev A 02 19)
This is a description of Levothyroxine Sodium Tablets, USP, with NDC number 70934-274-30 and a strength of 112 mcg, or 0.112mg. The package contains 30 tablets. There is information regarding an "Uty s ek 59 12," which is unclear but may be related to product expiration or manufacture. There is also mention of "i Cheme" and "Loty st ek, 517 by Theea," which are unclear and may have been misread during .*
Label 75 (70934 292 30 Rev A 02 19)
Label 100 (70934 308 30 Rev A 03 19)
Label 150 (70934 314 30 Rev A 03 19)
Label 88 (70934 326 30 Rev A 04 19)
Chemical Structure (Levothyroxine Sodium Tablet Usp Jsp 1)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.